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Wards cohorting infected orthopaedic patients may be particularly prone to transmitting extended-spectrum
beta-lactamase-producing Enterobacteriaceae (ESBL-E). We analyze their epidemic pattern by performing molecular
typing of ESBL-E isolated from patients and healthcare workers (HCW) from our septic ward. Between March 2010
and November 2011, 186 patients were admitted. Among 565 anal swabs, ESBL-E were detected in 204 samples
from 45 patients, suggesting prolonged carriage in affected patients. Among 25 cases with identical ESBL-E species
and positive epidemiological links, only 9 were really attributable to our service. We also screened 41 healthcare
workers (HCW) on 49 occasions during the study period. Six samples (13%) were positive. None of the ESBL-E
detected in HCW were related to any of the patient isolates. Among 60 environmental samples taken at the peak
of the epidemic none revealed ESBL-E. We conclude that HCW also were anal carriers of ESBL-E, however the ESBL-
strains from the HCW were not the same strains isolated from patients in the septic ward. Moreover, the
epidemiological attribution of ESBL by simple vicinity, timing, and species identification might grossly overestimate
transmission within a given unit.
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Orthopaedic surgical site infections are often associated
with substantial morbidity and exorbitant costs, and are
challenging to treat, especially in case of multi-resistant
pathogens or presence of implants (Uçkay et al. 2010;
Martinez-Pastor et al. 2010). Thus, to protect uninfected
implant patients, many centres cohort infected patients
in specialized septic wards, although the scientific bene-
fit for this practice is lacking.
Extended-spectrum beta-lactamase producing Entero-
bacteriaceae (ESBL-E) are emerging worldwide in hospitals
(Fankhauser et al. 2009) and in the community (Kader &
Kamath 2009). Septic wards are an ideal place for their pro-
liferation (Martinez-Pastor et al. 2010; Uçkay et al. 2009a)* Correspondence: ilker.uckay@hcuge.ch
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penicillins and cephalosporins, long hospital stays with in-
tensive close nursing and physiotherapy for multi-morbid
and immobile patients, high prevalence of open wounds,
decubitus ulcers or external fixation devices, and lack of
established decolonization protocols for ESBL-E.
In this study, we assessed the epidemiology of ESBL-E
in our septic orthopedic ward by typing and individual
epidemiological attribution of the source of acquisition.
We also examined the possible role of healthcare
workers (HCW) with anal ESBL-E colonization on pa-
tients in this ward.Setting
The University of Geneva Hospitals is a 2200-bed tertiary
healthcare center. The Orthopedic and Traumatology Ser-
vice has 132 acute care beds with a septic orthopaedic ward
of 24 beds, 4 surgeons, 19 nurses and 7 auxiliary nurses, 2
physiotherapists, 1 cleaning specialist, 1 infectious diseases
physician with specialisation in infection control andis an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 Epidemic curve of ESBL anal colonization in our septic orthopaedic ward. Horizontal axis: Study years stratified in quarters. Vertical
axis: Number of positive ESBL isolates on the septic ward. The zero lines divide community-acquired cases (above) from nosocomially acquired
cases (below). Grey cases are isolates without genotypic relation to other isolates. Genotypically identical strains are marked with numbers
(for example isolate 5 occurs three times).
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vice (5 nurses) for 5,000 annual ambulatory consultations.ESBL-E policy on the ward
Since 2009, admissions on the septic ward with a prob-
able hospital stay beyond 3 days have been screened for
ESBL-E (1 anal swab); unless the patient is known to be
positive or is transferred from another ward where
screening has been performed in the last few days. Pa-
tients with a history of ESBL-E carriage are flagged in a
computerized alert system and put in pre-emptive con-
tact isolation. This attitude also applies to patients trans-
ferred from abroad (Fankhauser et al. 2009), roommates
of index patients (Fankhauser et al. 2009) or during out-
breaks, when weekly patient screenings are performed.
Routine antibiotic prophylaxis for orthopedic surgery
does not cover ESBL-E.
ESBL-E carriers remain contact-isolated throughout their
hospital stay with no decolonization performed. Their
rooms, toilets and floors are cleaned with 80% magnesium
monoperoxyphthalate hexahydrate (DismozonW, Bode
Chemie, Hamburg, Germany) or troclosene 2.5% during
outbreaks. Hand hygiene is continuously promoted accor-
ding to hospital policy. Observed adherence to hand hy-
giene recommendations (Sax et al. 2007) ranges between
56% and 80% of indicated opportunities. Voluntary and
anonymzed ESBL-E screenings are offered to HCW.Microbiological procedures
On admission, anal ESBL-E carriage is detected by a
commercial chromogenic agar (chromID ESBL medium,
bioMérieux, Marcy l’Etoile, France). For this study we
typed ESBL-E isolates using repetitive sequence-based PCR
(DiversiLabW, bioMérieux, Marcy l’Etoile, France) (Brolund
et al. 2010). ESBL isolates with a similarity of ≥ 97.5% were
considered indistinguishable.
Results
Between March 2010 and November 2011, 186 patients
were admitted from the community and 1335 transferred
from other institutions, totaling 12,401 patient-days with an
average length of hospital stay of 27 days. Bed occupancy
averaged 83%.
Among 565 anal swabs, ESBL-E was detected in 204
samples from 45 patients, suggesting prolonged carriage in
affected patients. In six patients, two different ESBL-E
strains were detected, and 3 patients carried three distinct
isolates. Among the 45 positive patients, 29 (64%) were
detected during the first three days of admission, the re-
mainder after a median of 13 days of hospitalization, range
7–52 d). At the time of sampling, 26 patients received anti-
biotic therapy without clinical activity against their respect-
ive ESBL-E; a further seven patients were treated with
antibiotics which their ESBL-E strains were susceptible to
in vitro (carbapenems or quinolones). Most positive pa-
tients were asymptomatically colonized with ESBL-E. Two
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which one was acquired on our ward. No urinary tract,
other implant infections or soft tissue infections due to
ESBL were witnessed. The isolated ESBL-E were E. coli
(n = 39), Enterobacter spp (8), Citrobacter spp (3), Klebsiella
pneumoniae (1), Morganella morganii (1), and Proteus
vulgaris (1).
We also screened 41 HCW on 49 occasions during the
study period. Six samples (13%) were positive. Among 60
environmental samples taken at the peak of the epidemic
(room floors, beds, curtains, tables, doors, offices, com-
puters, telephones, kitchen, physiotherapy material, and toi-
lets), none revealed ESBL-E.
Genotyping
Epidemiological attribution alone was considered as insuffi-
cient to prove nosocomial transmission; e.g., two epidemio-
logically related patients with an E. coli carriage may reveal
in fact different isolates when typing is performed. On the
other hand, two identical ESBL-E strains found on
admission may occur in patients that were never hospital-
ized in our service. These latter cases were regarded as
community-acquired, although there might have been a
cross-transmission in another service or another hospital
before.
Among the 45 positive patients, we identified few clusters
of likely nosocomial transmissions in our ward (9 patients;
Figure 1). The rest were either unrelated or lacked an epi-
demiological relationship within the orthopedic service,
since these ESBL-E were identified on admission in patients
that had never been hospitalized before in our unit. With-
out molecular typing, we would have recorded 25 pre-
sumed “nosocomial” cases attributed to our ward. None of
the ESBL-E detected in HCW were related to any of the pa-
tient isolates.
Discussion
We report three interesting findings.
First, HCW may also be anal carriers, but their strains
might be different from the patients’; even if these reveal
long hospital stays. While no study so far has investigated
prevalence or incidence of anal ESBL-E carriage among
HCW, it is not per se surprising that HCW become anal
carriers, as also a substantial part of general population
may be carriers nowadays (Kader & Kamath 2009). In an
Egyptian study, ESBL-E hand colonization among HCW
was 2% (Rahman et al. 2010). Unfortunately, despite 13%
prevalence among voluntarily screened HCW, we could
not explain why there was no matching at all with the pa-
tients’ ESBL-E epidemic.
Second, among 25 cases with identical ESBL-E species
and positive epidemiological links, only nine were attribut-
able to our service. This underlines that epidemiological
attribution of ESBL-E by simple vicinity, timing, andspecies identification might grossly overestimate transmis-
sion within a given unit.
Finally, the rationale for systematic ESBL-E screening
(either on admission or periodically) in an orthopaedic
ward can be questioned. Although 565 samples have been
performed on our septic ward alone, only one nosocomial
ESBL-E infection was attributed to our unit. While this re-
lation might appear to lack cost-effectiveness, a regular ana-
lysis regarding the accuracy of ESBL-E detection in
orthopaedic surgery is lacking in the literature. Epidemio-
logically speaking, ESBL-E are a rare cause of orthopaedic
site infections in resource-rich settings (Martinez-Pastor
et al. 2010; Uçkay et al. 2009a).
Our study has limitations. It is a single-centre study
with small sample size and no systematized screening of
patients or HCW. In Switzerland, a non-voluntary sam-
pling of HCW is impossible. The DiversiLab system may
be less accurate than other techniques such as multilocus
sequence typing (Brolund et al. 2010). Likewise, the point
at which genetic relatedness is determined remains arbi-
trary. We have chosen a very conservative threshold of
97.5%.
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